Anna Ignatova

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology(Current)

Anna Ignatova is an author at Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology specializing in medicine, molecular oncology, and braf v600 mutations.

ORCID

Publications per year

2021–2023

Publications

Vemurafenib combined with cladribine and cytarabine results in durable remission of pediatric BRAF V600E–positive LCH

D. A. Evseev, D. S. Osipova, Anna Ignatova et al. · Blood Advances · 2023 · 29 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Vemurafenib provides a rapid and robust clinical response in pediatric Langerhans cell histiocytosis with the BRAF V600E mutation but does not eliminate low-level minimal residual disease per ddPCR using cell-free circulating DNA

D. A. Evseev, D. S. Osipova, Anna Ignatova et al. · International Journal of Hematology · 2021 · 28 citations

Medicine, Molecular Biology, Molecular Genetics +14

Development of a centralised triage centre for children with cancer and blood disorders in response to the humanitarian crisis in Ukraine

Marta Salek, Alexandra S. Mueller, Inna Alanbousi et al. · The Lancet Oncology · 2023 · 14 citations

Medicine, Oncology, Pediatrics +16

1–3 of 3